Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Hepatocellular carcinoma (HCC) presents a significant health burden in China.
• Cell division cycle 20 homolog (CDC20) is implicated in various cancers.
• The prognostic role of CDC20 in HCC requires further investigation.

Purpose of the Study:

• To investigate the association between CDC20 expression and the prognosis of HCC patients.
• To determine if CDC20 can serve as a predictive biomarker for HCC outcomes.

Main Methods:

• Quantitative real-time polymerase chain reaction (qRT-PCR) to measure CDC20 expression in HCC and noncancerous tissues.
• Chi-square analysis for clinicopathological correlations.
• Kaplan-Meier and Cox regression analyses for survival assessment.

Main Results:

• CDC20 expression was significantly elevated in HCC tissues compared to adjacent noncancerous tissues.
• High CDC20 expression correlated with poor differentiation, advanced tumor-node-metastasis (TNM) stage, and lymphatic metastasis.
• Elevated CDC20 levels were associated with dismal overall survival rates in HCC patients.
• Multivariable Cox regression identified CDC20 as an independent prognostic factor for HCC (HR=2.354, P=0.016).

Conclusions:

• Overexpressed CDC20 is linked to unfavorable prognoses in HCC.
• CDC20 demonstrates potential as a reliable biomarker for predicting dismal outcomes in HCC patients.